Here we show that induction of transcription factor FoxO1 during ibrutinib therapy upregulates Rictor, an mTORC2 assembly protein, leading to phosphorylation of Akt, an essential molecule supporting CLL cell survival. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.